Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Enanta Pharmaceuticals (ENTA) over the last 4 years, with Q2 2015 value amounting to $2000.0.

  • Enanta Pharmaceuticals' Treasury Shares changed 0.0% to $2000.0 in Q2 2015 from the same period last year, while for Jun 2015 it was $2000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $2000.0 for FY2014, which is 0.0% changed from last year.
  • Enanta Pharmaceuticals' Treasury Shares amounted to $408000.0 in Q3 2025, which was down 467.29% from $414000.0 recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Treasury Shares registered a high of $455000.0 during Q4 2023, and its lowest value of $117000.0 during Q3 2021.
  • Over the past 5 years, Enanta Pharmaceuticals' median Treasury Shares value was $414000.0 (recorded in 2025), while the average stood at $335368.4.
  • Over the last 5 years, Enanta Pharmaceuticals' Treasury Shares had its largest YoY gain of 0.0% in 2013, and its largest YoY loss of 0.0% in 2013.
  • Quarter analysis of 4 years shows Enanta Pharmaceuticals' Treasury Shares stood at $2000.0 in 2012, then changed by 0.0% to $2000.0 in 2013, then changed by 0.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
  • Its last three reported values are $2000.0 in Q2 2015, $2000.0 for Q1 2015, and $2000.0 during Q4 2014.